32 results:
11. Download materials Cerebrolysin  
Download area Cerebrolysin> Cerebrolysin Stroke Downloads> Cerebrolysin Dementia Downloads> Cerebrolysin TBI Downloads  
12. Dosage recommendation  
AdministrationDOSAGE RECOMMENDATION In stroke and TBI Cerebrolysin should be administered as an adjunctive treatment to standard TBI care. The administration initiated optimally as soon as…  
13. Terms of Use  
Terms of Use Last updated: 11.04.2018 1. Scope of Agreement 1.1. The use of the services on the non-public product sites on www.cerebrolysin.com ("Website") is offered to you by EVER Neuro…  
14. Disclaimer  
Disclaimer EVER Pharma undertakes all appropriate effort to make correct and complete information available on this website, but assumes no responsibility, guarantees or liability whatsoever that…  
15. Adverse Events  
Dr. Barbara KDownload In case of emergencies please dial: Tel.: +43 7665 20 555 - 0  
16. Contact EVER Pharma  
Contact EVER PharmaEVER Neuro Pharma GmbH Oberburgau 3 4866 Unterach, Austria Phone: +43 7665 20555 0 Fax: +43 7665 20555 910 E-Mail: office(at)everpharma.com www.everpharma.com  
17. Links  
Country specific informationRussiaWWW.CEREBROLYSIN.RUWWW.NEUROLOGIC.RUUkrainewww.cerebrolysin.com.uaKazakhstanwww.cerebrolysin.kzwww.insult.kzPolandwww.neuroaktywacja.plLatin…  
18. News  
News  
19. TBI  
Disease Traumatic brain injury (TBI) affects approx. 15 million1 individuals annually worldwide and is one of the leading causes of death. It is associated with high rates of hospitalization,…  
20. Clinical efficacy in dementia  
Clinical efficacy and patient benefits To date, more than 3000 patients have been included in clinical trials evaluating the efficacy of Cerebrolysin in Alzheimer's disease and vascular dementia.…  

Search results 11 until 20 of 32